Advertisement

Loading...

The BC Bud Corporation

BCBC.CNCNQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.04
$0.01(33.33%)
Canadian Market opens in 16h 37m

The BC Bud Corporation Fundamental Analysis

The BC Bud Corporation (BCBC.CN) shows weak financial fundamentals with a PE ratio of -1.80, profit margin of -19.91%, and ROE of -1.93%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio0.00

Areas of Concern

ROE-1.93%
Operating Margin-19.89%
Cash Position0.19%
Current Ratio0.96
We analyze BCBC.CN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -2101.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-2101.5/100

We analyze BCBC.CN's fundamental strength across five key dimensions:

Efficiency Score

Weak

BCBC.CN struggles to generate sufficient returns from assets.

ROA > 10%
-1.94%

Valuation Score

Excellent

BCBC.CN trades at attractive valuation levels.

PE < 25
-1.80
PEG Ratio < 2
0.00

Growth Score

Weak

BCBC.CN faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Weak

BCBC.CN carries high financial risk with limited liquidity.

Debt/Equity < 1
37.83
Current Ratio > 1
0.96

Profitability Score

Weak

BCBC.CN struggles to sustain strong margins.

ROE > 15%
-192.85%
Net Margin ≥ 15%
-19.91%
Positive Free Cash Flow
No

Key Financial Metrics

Is BCBC.CN Expensive or Cheap?

P/E Ratio

BCBC.CN trades at -1.80 times earnings. This suggests potential undervaluation.

-1.80

PEG Ratio

When adjusting for growth, BCBC.CN's PEG of 0.00 indicates potential undervaluation.

0.00

Price to Book

The market values The BC Bud Corporation at 363.15 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

363.15

EV/EBITDA

Enterprise value stands at -4.01 times EBITDA. This is generally considered low.

-4.01

How Well Does BCBC.CN Make Money?

Net Profit Margin

For every $100 in sales, The BC Bud Corporation keeps $-19.91 as profit after all expenses.

-19.91%

Operating Margin

Core operations generate -19.89 in profit for every $100 in revenue, before interest and taxes.

-19.89%

ROE

Management delivers $-1.93 in profit for every $100 of shareholder equity.

-1.93%

ROA

The BC Bud Corporation generates $-1.94 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.94%

Following the Money - Real Cash Generation

Operating Cash Flow

The BC Bud Corporation generates limited operating cash flow of $-1.41M, signaling weaker underlying cash strength.

$-1.41M

Free Cash Flow

The BC Bud Corporation generates weak or negative free cash flow of $-1.41M, restricting financial flexibility.

$-1.41M

FCF Per Share

Each share generates $-0.01 in free cash annually.

$-0.01

FCF Yield

BCBC.CN converts -12.36% of its market value into free cash.

-12.36%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-1.80

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.003

vs 25 benchmark

P/B Ratio

Price to book value ratio

363.15

vs 25 benchmark

P/S Ratio

Price to sales ratio

81.63

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

37.83

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.96

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-1.93

vs 25 benchmark

ROA

Return on assets percentage

-1.94

vs 25 benchmark

ROCE

Return on capital employed

-201.78

vs 25 benchmark

How BCBC.CN Stacks Against Its Sector Peers

MetricBCBC.CN ValueSector AveragePerformance
P/E Ratio-1.8027.91 Better (Cheaper)
ROE-192.85%687.00% Weak
Net Margin-1990.83%-45285.00% (disorted) Weak
Debt/Equity37.830.33 Weak (High Leverage)
Current Ratio0.962795.76 Weak Liquidity
ROA-193.65%-13557.00% (disorted) Weak

BCBC.CN outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews The BC Bud Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ